Last price paid | 3.77 | |
Change | +2.72% [ +0.10 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 22.02.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +134.47% |
Year to date (YTD) | n.a. |
1 month | +3.86% |
3 months | +81.25% |
1 year | n.a. |
3 years | n.a. |
Issue price | 1.61 |
Underlying price on issue | 40.06 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305138005 |
Symbol | IABU0Z |
Security | 130513800 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | ABB N, CH0012221716 |
Underlying ISIN | CH0012221716 |
Funding level | 32.067600 |
Stop-loss level | 32.985700 |
Distance to stop-loss level | 35.07% |
Long/Short type | Long |
Subscription ratio | 5.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 20.02.2024 |
Premium | 0.27% |
Premium p.a. | n.a. |
Leverage | 2.69 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 18.736300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Alcon AG | 81.50 |
Partners Group Ho... | 1'236.00 |
NOVARTIS N | 100.06 |
UBS | 27.90 |
Sika AG | 263.80 |
Name | Price |
---|---|
KUEHNE & NAGEL | 255.40 |
Swiss Life Hldg | 673.00 |
ABB Ltd | 50.74 |
GEBERIT N | 552.00 |
Givaudan | 4'362.00 |